202 related articles for article (PubMed ID: 17494694)
21. Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity.
Yi CW; Wang LQ; Huang JJ; Pan K; Chen J; Liang Y
Sci Rep; 2018 Aug; 8(1):12603. PubMed ID: 30135544
[TBL] [Abstract][Full Text] [Related]
22. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
[TBL] [Abstract][Full Text] [Related]
24. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
25. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
26. Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.
Yuan Z; Yang L; Chen B; Zhu T; Hassan MF; Yin X; Zhou X; Zhao D
J Neurochem; 2015 Jun; 133(5):722-9. PubMed ID: 25810062
[TBL] [Abstract][Full Text] [Related]
27. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
28. Cellular prion protein neuroprotective function: implications in prion diseases.
Roucou X; LeBlanc AC
J Mol Med (Berl); 2005 Jan; 83(1):3-11. PubMed ID: 15645198
[TBL] [Abstract][Full Text] [Related]
29. Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics.
Jetha NN; Semenchenko V; Wishart DS; Cashman NR; Marziali A
PLoS One; 2013; 8(2):e54982. PubMed ID: 23393562
[TBL] [Abstract][Full Text] [Related]
30. Removal of the glycosylation of prion protein provokes apoptosis in SF126.
Chen L; Yang Y; Han J; Zhang BY; Zhao L; Nie K; Wang XF; Li F; Gao C; Dong XP; Xu CM
J Biochem Mol Biol; 2007 Sep; 40(5):662-9. PubMed ID: 17927898
[TBL] [Abstract][Full Text] [Related]
31. Targeting of the prion protein to the cytosol: mechanisms and consequences.
Miesbauer M; Rambold AS; Winklhofer KF; Tatzelt J
Curr Issues Mol Biol; 2010; 12(2):109-18. PubMed ID: 19767654
[TBL] [Abstract][Full Text] [Related]
32. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
Wang X; Wang F; Sy MS; Ma J
J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection.
Stewart RS; Harris DA
J Biol Chem; 2003 Nov; 278(46):45960-8. PubMed ID: 12933795
[TBL] [Abstract][Full Text] [Related]
34. Molecular approaches to mechanisms of prion diseases.
Bratosiewicz-Wasik J; Wasik TJ; Liberski PP
Folia Neuropathol; 2004; 42 Suppl A():33-46. PubMed ID: 15449458
[TBL] [Abstract][Full Text] [Related]
35. Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.
Rambold AS; Miesbauer M; Rapaport D; Bartke T; Baier M; Winklhofer KF; Tatzelt J
Mol Biol Cell; 2006 Aug; 17(8):3356-68. PubMed ID: 16707568
[TBL] [Abstract][Full Text] [Related]
36. [Prions and their biology].
Gasset M; Westaway D
Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
[TBL] [Abstract][Full Text] [Related]
37. The unfolding of the prion protein sheds light on the mechanisms of prion susceptibility and species barrier.
Robinson PJ; Pinheiro TJ
Biochemistry; 2009 Sep; 48(36):8551-8. PubMed ID: 19655812
[TBL] [Abstract][Full Text] [Related]
38. Biology and genetics of prion diseases.
Prusiner SB
Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
[TBL] [Abstract][Full Text] [Related]
39. Role of prion protein aggregation in neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Florio T
Int J Mol Sci; 2012; 13(7):8648-8669. PubMed ID: 22942726
[TBL] [Abstract][Full Text] [Related]
40. Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit.
Senatore A; Colleoni S; Verderio C; Restelli E; Morini R; Condliffe SB; Bertani I; Mantovani S; Canovi M; Micotti E; Forloni G; Dolphin AC; Matteoli M; Gobbi M; Chiesa R
Neuron; 2012 Apr; 74(2):300-13. PubMed ID: 22542184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
